IPO registrations (S-1, F-1) · Registrants
Anixa Biosciences Inc
- SEC CIK
- 715446 · filings on EDGAR ↗
- Name on the registration
- ITUS Corp
- Former names
- ITUS Corp (2014–2018); COPYTELE INC (1995–2014)
- Registration
- Form S-1, first filed 2013-04-24, last 2017-01-27; 3 initial registrations, 2 amendments
- Outcome
- Declared effective 2013-06-14; withdrawal requested 2017-03-27
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, San Jose, CA 95118
- EIN
- 11-2622630
- Ticker
- ANIX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Anixa Biosciences Inc on the corporate pages
Offering terms
- Shares offered
- 947,606
- Listing
- Nasdaq under the symbol ITUS
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ANIXA BIOSCIENCES, INC. EXACT (EIN (EXACT))
- SEC filer: Anixa Biosciences Inc EXACT (CIK (EXACT))
- Person page: Lewis H Titterton Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-04-24 | S-1 | S-1 (registration) | COPYTELE INC | 0001513162-13-000309 ↗ |
| 2013-06-14 | S-1/A | S-1/A (amendment) | COPYTELE INC | 0001513162-13-000438 ↗ |
| 2013-06-14 | EFFECT | EFFECT (declared effective) | COPYTELE INC | 9999999995-13-001804 ↗ |
| 2014-02-05 | EFFECT | EFFECT (declared effective) | COPYTELE INC | 9999999995-14-000321 ↗ |
| 2014-04-25 | EFFECT | EFFECT (declared effective) | COPYTELE INC | 9999999995-14-001145 ↗ |
| 2014-05-08 | EFFECT | EFFECT (declared effective) | COPYTELE INC | 9999999995-14-001371 ↗ |
| 2014-12-08 | S-1 | S-1 (registration) | ITUS Corp | 0001513162-14-000635 ↗ |
| 2015-03-04 | S-1/A | S-1/A (amendment) | ITUS Corp | 0001513162-15-000108 ↗ |
| 2015-03-13 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-15-000603 ↗ |
| 2015-03-19 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-15-000640 ↗ |
| 2015-09-18 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-15-002544 ↗ |
| 2016-02-02 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-16-003645 ↗ |
| 2017-01-27 | S-1 | S-1 (registration) | ITUS Corp | 0001513162-17-000027 ↗ |
| 2017-03-27 | RW | RW (withdrawal request) | ITUS Corp | 0001513162-17-000089 ↗ |
| 2017-04-10 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-17-000785 ↗ |
| 2017-10-26 | EFFECT | EFFECT (declared effective) | ITUS Corp | 9999999995-17-002798 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-01-27 | S-1 | registration statement | $5.04 | 947,606 | $4,775,934 | Nasdaq ITUS | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| HERMS HENRY P | Director,Officer; Officer | Chief Financial Officer; Vice President - Finance & CFO; Vice President-Finance & CFO; VP Finance and CFO; V.P., Finance & CFO; VP - Finance & CFO; VP, Finance & CFO; VP-Finance & CFO | 24 | 2006–2016 | |
| KRUSOS DENIS A | Director,Officer | Chief Executive Offcer; Chief Executive Officer | 15 | 2006–2012 | |
| LAROUNIS GEORGE P | Director | 10 | 2006–2012 | ||
| DISANTO FRANK J | Director,Officer | President | 4 | 2006–2007 | |
| Mars Overseas LTD | TenPercentOwner | 1 | 2007 | ||
| Titterton Lewis H jr | Director; Director,Officer | Chief Executive Officer | 98 | 2010–2026 | person page Fuzzy |
| Williams Kent B. | Director | 5 | 2012–2014 | ||
| JOHNSON BRUCE F | Director | 63 | 2012–2017 | ||
| Roop John H. | Officer | Sr. Vice President-Engineering | 3 | 2012–2014 | |
| BERMAN ROBERT ANDREW | Director,Officer; Officer | President and CEO; President & CEO | 25 | 2012–2017 | |
| KUMAR AMIT | Director; Director,Officer; Officer | Chief Executive Officer | 82 | 2012–2026 | |
| Stender Tisha | Officer | Chief Operating Officer | 2 | 2014 | |
| Fox Dale | Director | 6 | 2014–2017 | ||
| Belz Andrea | Director | 3 | 2014–2015 | ||
| Baskies Arnold M | Director | 30 | 2016–2026 | ||
| MONAHAN JOHN J | Director | 11 | 2016–2020 | ||
| Catelani Michael | Director,Officer; Officer | Chief Financial Officer; Chief Operating Officer; COO & CFO; President; President, COO & CFO; President, COO, & CFO | 33 | 2016–2026 | |
| WILLIAMS RICHARD H | Director | 4 | 2017–2018 | ||
| Cavalier David | Director | 5 | 2018–2020 | ||
| Gottschalk Emily | Director | 12 | 2019–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | ANIXA BIOSCIENCES, INC. | CA | Form 5500 (employee benefit plans) | name and state |
| Patent assignee | Anixa Biosciences, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | Anixa Biosciences Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | ANIXA BIOSCIENCES, INC. | EIN (EXACT) | ||
| Person page | Lewis H Titterton Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- RIGEL PHARMACEUTICALS INC CA
- Diadexus, Inc. CA
- CymaBay Therapeutics, Inc. CA
- CRESCENDO PHARMACEUTICALS CORP CA
- SPIROS DEVELOPMENT CORP II INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health